tildrakizumab
Showing 1 - 10 of 10
Tildrakizumab in Treatment of Genital Psoriasis
Not yet recruiting
- Genital Psoriasis
- Tildrakizumab
- (no location specified)
Sep 1, 2023
Switching FromBiologic Treatment to Tildrakizumab Using
Not yet recruiting
- Plaque Psoriasis
- Tildrakizumab
- (no location specified)
Sep 1, 2023
Skin and Connective Tissue Diseases, Skin Diseases, Pigmentation Disorder Trial in Sydney (Tildrakizumab)
Recruiting
- Skin and Connective Tissue Diseases
- +5 more
- Tildrakizumab
-
Sydney, New South Wales, AustraliaPremier Specialists Pty Ltd
Apr 19, 2022
Plaque Psoriasis Trial in Freising (Tildrakizumab)
Recruiting
- Plaque Psoriasis
- Tildrakizumab
-
Freising, Bavaria, GermanyHaut- und Laserzentrum Freising
Dec 24, 2021
Hematologic Malignancies Trial in Milwaukee (Tildrakizumab)
Recruiting
- Hematologic Malignancies
- Tildrakizumab
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Sep 8, 2021
Psoriasis Trial in Boston (Tildrakizumab)
Recruiting
- Psoriasis
- Tildrakizumab
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 22, 2021
Chronic Plaque Psoriasis, Moderate to Severe Nail Psoriasis Trial in Australia, United States (Tildrakizumab, Placebo)
Recruiting
- Chronic Plaque Psoriasis
- Moderate to Severe Nail Psoriasis
- Tildrakizumab
- Placebo
-
Encinitas, California
- +21 more
Feb 23, 2022
Tildrakizumab in Moderate to Severe Plaque Psoriasis in Routine
Recruiting
- Plaque Psoriasis
- Tildrakizumab
-
Wien, Austria
- +21 more
Feb 19, 2021
